About Zepteon
Zepteon is a company based in Boston (United States) founded in 2012.. Zepteon has raised $210 thousand across 1 funding round. Zepteon offers products and services including Glycap-3A. Zepteon operates in a competitive market with competitors including Isolere Bio, ExBiome, REV-MED, VIRAPUR and Norgen Biotek, among others.
- Headquarter Boston, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Zepteon, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$210 K (USD)
in 1 rounds
-
Latest Funding Round
$210 K (USD), Seed
Apr 09, 2015
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Zepteon
Zepteon offers a comprehensive portfolio of products and services, including Glycap-3A. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Separates nonfucosylated or bisected IgG glycoforms for enhanced antibody production.
Unlock access to complete
Unlock access to complete
Funding Insights of Zepteon
Zepteon has successfully raised a total of $210K through 1 strategic funding round. The most recent funding activity was a Seed round of $210 thousand completed in April 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $210,000
-
First Round
First Round
(09 Apr 2015)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2015 | Amount | Seed - Zepteon | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Zepteon
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Zepteon
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Zepteon Comparisons
Competitors of Zepteon
Zepteon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Isolere Bio, ExBiome, REV-MED, VIRAPUR and Norgen Biotek, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
A platform for biotherapeutics purification is provided using TFF technology.
|
|
| domain | founded_year | HQ Location |
Develops innovative diagnostic technologies for cancer detection from blood samples.
|
|
| domain | founded_year | HQ Location |
Limited details on core medical activities are available.
|
|
| domain | founded_year | HQ Location |
Provides viral reagents and assay services for scientific and medical research.
|
|
| domain | founded_year | HQ Location |
Offers kits and services for RNA, DNA extraction, purification, and genomics research.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Zepteon
When was Zepteon founded?
Zepteon was founded in 2012 and raised its 1st funding round 3 years after it was founded.
Where is Zepteon located?
Zepteon is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Is Zepteon a funded company?
Zepteon is a funded company, having raised a total of $210K across 1 funding round to date. The company's 1st funding round was a Seed of $210K, raised on Apr 09, 2015.
What does Zepteon do?
Founded in 2012 and based in Boston, United States, Zepteon operates in the biopharmaceutical sector. Technology focused on antibody development and manufacturing is provided through Glycap-3A chromatography resin, which separates high-potency antibodies from mixtures. This approach supports drug potency tuning, regulatory structure-function characterization, and production of biosimilars, biobetters, and novel therapeutics. Services are extended to monoclonal antibody and plasma-derived antibody markets via fees, milestones, and royalties.
Who are the top competitors of Zepteon?
Zepteon's top competitors include Isolere Bio, GenTegra and REV-MED.
What products or services does Zepteon offer?
Zepteon offers Glycap-3A.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.